Ironwood Pharmaceuticals | IRWD - 資産





資産 変化する 日付
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Almirall EUR 2.37B 29.97M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amarin USD 624.36M 21.4M 2026-06
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
Charles River Laboratories USD 7.73B 594.89M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Incyte USD 7.87B 533.53M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 217.87M 38.97M 2026-03
Moderna USD 10.96B 527M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Pacira USD 1.21B 56.38M 2026-03
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Takeda JPY 15.66T 210.16B 2026-06
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12